Published in Lab Anim Sci on October 01, 1979
Definition of human rotavirus serotypes by plaque reduction assay. Infect Immun (1982) 5.19
Antigenic comparisons of two new rotaviruses from rhesus monkeys. J Clin Microbiol (1980) 2.39
Infectious agent and immune response characteristics of chronic enterocolitis in captive rhesus macaques. Infect Immun (2003) 1.50
Defining T-cell-mediated immune responses in rotavirus-infected juvenile rhesus macaques. J Virol (2004) 1.00
Risk factor analysis may provide clues to diarrhea prevention in outdoor-housed rhesus macaques (Macaca mulatta). Am J Primatol (2013) 0.82
The value of extended pedigrees for next-generation analysis of complex disease in the rhesus macaque. ILAR J (2013) 0.82
Case control comparison of enteric viromes in captive rhesus macaques with acute or idiopathic chronic diarrhea. J Virol (2017) 0.75
Isolation of lymphocytopathic retroviruses from San Francisco patients with AIDS. Science (1984) 15.82
An apparently new enterovirus isolated from patients with disease of the central nervous system. J Infect Dis (1974) 6.22
Rochalimaea henselae infection. A new zoonosis with the domestic cat as reservoir. JAMA (1994) 5.98
A virus in Beechey ground squirrels that is related to hepatitis B virus of humans. Proc Natl Acad Sci U S A (1980) 5.63
Case definitions, diagnostic algorithms, and priorities in encephalitis: consensus statement of the international encephalitis consortium. Clin Infect Dis (2013) 4.51
Lyophilized combination pools of enterovirus equine antisera: preparation and test procedures for the identification of field strains of 42 enteroviruses. Bull World Health Organ (1973) 4.27
Caring for pets of immunocompromised persons. J Am Vet Med Assoc (1994) 3.89
Variables of the rubella hemagglutination-inhibition test system and their effect on antigen and antibody titers. Appl Microbiol (1970) 3.12
Anti-NMDA receptor encephalitis: report of ten cases and comparison with viral encephalitis. Eur J Clin Microbiol Infect Dis (2009) 3.11
Bartonella henselae prevalence in domestic cats in California: risk factors and association between bacteremia and antibody titers. J Clin Microbiol (1995) 2.83
Immunofluorescent staining in the laboratory diagnosis of varicella-zoster virus infections. J Lab Clin Med (1965) 2.67
Comparative sensitivity of various cell culture systems for isolation of viruses from wastewater and fecal samples. Appl Environ Microbiol (1978) 2.64
Immunological relationship between herpes simplex and varicella-zoster viruses demonstrated by complement-fixation, neutralization and fluorescent antibody tests. J Gen Virol (1969) 2.60
The isolation and characterization of a Norwalk virus-specific cDNA. J Clin Invest (1991) 2.42
Antigenic comparisons of two new rotaviruses from rhesus monkeys. J Clin Microbiol (1980) 2.39
Enterovirus type 70: the etiologic agent of pandemic acute haemorrhagic conjunctivitis. Bull World Health Organ (1973) 2.29
Comparison of direct immunofluorescence and direct immunoperoxidase procedures for detection of herpes simplex virus antigen in lesion specimens. J Clin Microbiol (1983) 2.27
Antibody assays for varicella-zoster virus: comparison of enzyme immunoassay with neutralization, immune adherence hemagglutination, and complement fixation. J Clin Microbiol (1978) 2.26
Percutaneous transluminal balloon valvuloplasty for pulmonary valve stenosis. Circulation (1984) 2.21
Neutralizing antibody responses to varicella-zoster virus. Infect Immun (1975) 2.21
Direct immunofluorescence staining for detection of herpes simplex and varicella-zoster virus antigens in vesicular lesions and certain tissue specimens. J Clin Microbiol (1980) 2.18
Subacute sclerosing panencephalitis in the differential diagnosis of encephalitis. Neurology (2004) 2.18
Behavioral risk factors for disease and preventive health practices among lesbians. Am J Public Health (2001) 2.12
Simian AIDS: isolation of a type D retrovirus and transmission of the disease. Science (1984) 2.10
Antigen requirements, sensitivity, and specificity of enzyme immunoassays for measles and rubella viral antibodies. J Clin Microbiol (1979) 2.07
The metabolism of hydroxylamine to nitrite by Nitrosomonas. Biochem J (1964) 1.95
Rubella complement-fixing antigens derived from the fluid and cellular phases of infected BHK-21 cells: extraction of cell-associated antigen with alkaline buffers. J Immunol (1966) 1.94
Propagation and isolation of group A coxsackieviruses in RD cells. J Clin Microbiol (1975) 1.93
Virulence markers of mesophilic aeromonads: association of the autoagglutination phenomenon with mouse pathogenicity and the presence of a peripheral cell-associated layer. Infect Immun (1987) 1.92
Monoclonal antibodies for rapid, strain-specific identification of influenza virus isolates. J Clin Microbiol (1982) 1.89
Association of group B coxsackie viruses with cases of pericarditis, myocarditis, or pleurodynia by demonstration of immunoglobulin M antibody. Infect Immun (1973) 1.86
Filter paper disc method of collecting whole blood for serologic studies in children. Am J Epidemiol (1966) 1.82
Complement-fixing antibody in human sera reactive with viral and soluble antigens of cytomegalovirus. J Clin Microbiol (1975) 1.81
Characterization of antibodies produced in natural and experimental coxsackievirus infections. J Immunol (1968) 1.81
Demonstration of rubella IgM antibody by indirect fluorescent antibody staining, sucrose density gradient centrifugation and mercaptoethanol reduction. Intervirology (1973) 1.78
Modified hemagglutination-inhibition test for rubella employing human group O erythrocytes. Appl Microbiol (1972) 1.77
Improved glycine-extracted complement-fixing antigen for human cytomegalovirus. J Clin Microbiol (1977) 1.73
Evaluation of enterovirus immune horse serum pools for identification of virus field strains. Bull World Health Organ (1971) 1.72
Mechanical devices for arterial occlusion. Am J Roentgenol Radium Ther Nucl Med (1975) 1.72
Improved yields of cell-free varicella-zoster virus. Infect Immun (1976) 1.71
Surgery for occult rectal prolapse. Colorectal Dis (2004) 1.70
Anti-complement immunofluorescence test for antibodies to human cytomegalovirus. J Clin Microbiol (1977) 1.66
Solid phase radioimmunoassay for identification of Herpesvirus hominis types 1 and 2 from clinical materials. Appl Microbiol (1974) 1.63
On the nature of complement-fixing antibodies to Mycoplasma pneumoniae. J Immunol (1966) 1.63
Solid phase radioimmunoassay for typing herpes simplex viral antibodies in human sera. J Clin Microbiol (1975) 1.63
Preoperative but not postoperative systemic inflammatory response correlates with survival in colorectal cancer. Br J Surg (2007) 1.62
Penetration and replication of Edwardsiella spp. in HEp-2 cells. Infect Immun (1991) 1.62
Comparison of immunofluorescence and immunoperoxidase staining for identification of rubella virus isolates. J Clin Microbiol (1978) 1.59
Identification of rubella virus isolates by immunofluorescent staining, and a comparison of the sensitivity of three cell culture systems for recovery of virus. J Lab Clin Med (1966) 1.58
Neutralizing, hemagglutination-inhibiting and group complement-fixing antibody responses in human adenovirus infections. J Immunol (1966) 1.57
The complement-fixing antigen of rubella virus. Proc Soc Exp Biol Med (1966) 1.57
Comparison of the prognostic value of selected markers of the systemic inflammatory response in patients with colorectal cancer. Br J Cancer (2007) 1.57
Spinocerebellar ataxia type 6: gaze-evoked and vertical nystagmus, Purkinje cell degeneration, and variable age of onset. Ann Neurol (1997) 1.56
Complement fixation and immunodiffusion tests for assay of hepatitis-associated "Australia" antigen and antibodies. J Immunol (1970) 1.54
Free radical activity and lipid soluble anti-oxidant vitamin status in patients with long-term ileal pouch-anal anastomosis. Colorectal Dis (2008) 1.53
Etiology and outcome of diarrhea after marrow transplantation: a prospective study. Gastroenterology (1994) 1.51
Varicella-zoster viral glycoproteins analyzed with monoclonal antibodies. J Virol (1984) 1.50
Vitamin B12 deficiency following restorative proctocolectomy. Colorectal Dis (2007) 1.49
Antisera to human cytomegalovirus produced in hamsters: reactivity in radioimmunoassay and other antibody assay systems. Infect Immun (1976) 1.49
Surface properties of autoagglutinating mesophilic aeromonads. Infect Immun (1988) 1.48
Strategy for the surgical management of patients with idiopathic megarectum and megacolon. Br J Surg (2001) 1.48
Identification of patients likely to benefit from biofeedback for outlet obstruction constipation. Br J Surg (1999) 1.48
Plaque reduction neutralization test for human cytomegalovirus based upon enhanced uptake of neutral red by virus-infected cells. J Clin Microbiol (1976) 1.45
Enterovirus etiology of the 1970 Singapore epidemic of acute conjunctivitis. Intervirology (1974) 1.45
A 27-nm virus isolated during an outbreak of acute infectious nonbacterial gastroenteritis in a convalescent hospital: a possible new serotype. J Infect Dis (1981) 1.41
Transcatheter occlusion of abdominal tumors. Radiology (1976) 1.41
Management of patients with thyroid carcinoma: application of thallium-201 scintigraphy and magnetic resonance imaging. J Nucl Med (1990) 1.41
Colonic motility is abnormal before surgery for rectal prolapse. Br J Surg (1999) 1.40
Increased duration of low retinal slip velocities following retroequatorial placement of horizontal recti. J Pediatr Ophthalmol Strabismus (1996) 1.39
Epidemic of acquired immunodeficiency in rhesus monkeys. Lancet (1983) 1.39
Metachronous torsion of the appendix testis. Br J Urol (1994) 1.38
The value of an elastic tissue stain in detecting venous invasion in colorectal cancer. J Clin Pathol (2004) 1.37
Preoperative systemic inflammation predicts postoperative infectious complications in patients undergoing curative resection for colorectal cancer. Br J Cancer (2009) 1.35
Comparative sensitivity of the BGM cell line for isolation of enteric viruses. Health Lab Sci (1976) 1.35
Carrier cultures of human fetal diploid cells infected with coxsackievirus type B2. Arch Gesamte Virusforsch (1973) 1.34
Rubella virus hemagglutination with a wide variety of erythrocyte species. Appl Microbiol (1971) 1.34
Physical and immunologic properties of rubella antigens. J Immunol (1968) 1.33
Prognostic value of tumour necrosis and host inflammatory responses in colorectal cancer. Br J Surg (2011) 1.33
Major polypeptide of duck hepatitis B surface antigen particles. J Virol (1983) 1.32
Visual reading of enzyme immunofluorescence assays for human cytomegalovirus antibodies. J Clin Microbiol (1980) 1.32
Enzyme immunoassay versus plaque neutralization and other methods for determination of immune status to measles and varicella-zoster viruses and versus complement fixation for serodiagnosis of infections with those viruses. J Clin Microbiol (1985) 1.32
Electron microscopic study of the development of simian virus 40 by use of ferritin-labeled antibodies. J Virol (1967) 1.30
Inosinic acid dehydrogenase of sarcoma 180 cells. J Biol Chem (1968) 1.29
Dengue-2 vaccine: virological, immunological, and clinical responses of six yellow fever-immune recipients. Infect Immun (1981) 1.28
Hemadsorption and hemadsorption inhibition tests for rubella virus. Arch Gesamte Virusforsch (1968) 1.27
Dengue 2 vaccine: dose response in volunteers in relation to yellow fever immune status. J Infect Dis (1983) 1.27
Antigenic relationships among several simian varicella-like viruses and varicella-zoster virus. Infect Immun (1977) 1.27
Microneutralization test for the reoviruses. Application to detection and assay of antibodies in sera of laboratory animals. Proc Soc Exp Biol Med (1966) 1.26
Relative sensitivity of gel diffusion, complement fixation, and immunoelectroosmophoresis tests for detection of hepatitis-associated antigen and antibody. Appl Microbiol (1971) 1.26
The pathology of an epizootic of acquired immunodeficiency in rhesus macaques. Am J Pathol (1984) 1.26
Induction of lymphoma and associated xenotropic type C virus in C57L mice by whole-body irradiation. J Natl Cancer Inst (1976) 1.25
Demonstration of viral antibody activity in two immunoglobulin G subclasses in patients with varicella-zoster virus infection. J Immunol (1970) 1.23
Indirect hemagglutinating antibody response to Herpesvirus hominis types 1 and 2 in immunized laboratory animals and in natural infections of man. Appl Microbiol (1974) 1.23
Immunological relationship between delta herpesvirus of patas monkeys and varicells-zoster virus of humans. Infect Immun (1975) 1.23